Effect of tapentadol for the cancer pai
Phase 2
Not yet recruiting
- Conditions
- cancer patients
- Registration Number
- JPRN-UMIN000016414
- Lead Sponsor
- Higashi Sapporo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1) bad controlled liver, kidney, heart, lung , hypertension and infectious diseases 2) psychiatric diseases including depression 3) pregnancy or breast-feeding 4) intake of SNRI inhibitor 5) the cases whom the doctor decide not to be the indication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of pain NRS scores between neuropathic pain and nociceptive pain
- Secondary Outcome Measures
Name Time Method Comparison of tapentadol doses between neuropathic pain or nociceptive pain